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Introduction
For logistic, if not economic, reasons the larger clinical
chemistry departments handle much of their work by
automated multi-channel analysis. Their commonest purpose-
built equipment is the Technicon* SMA 12/60 analyser, first
introduced into the United Kingdom in 1969. It can process up
to 60 samples an hour and provides twelve analytical results on
each.
This speed of working is now becoming too slow: in some
hospitals an increasing workload is beginning to exceed the
capacity of the SMA 12/60 or its recent variants and, even
where it does not, staff spending less time with faster equipment
could then be redeployed. The Vickers** SP 120 analyser is
designed to meet present-day needs. It is an attachment to the
SMA 12/60, doubles its output and in so doing reduces its
reagent consumption and sample size. We report on its
performance.
This instrument will always be used in conjunction with the
Technicon SMA series for which it was designed. Its
attachment nature therefore simplified our task in several
respects to a straight-forward comparison of the 12/60 + 120
complex with the original 12/60, already well known-
Broughton et al[ 1]. In other respects our evaluation was based
on an accepted schedule recommended by Broughton et al [2]
with help from a similar report by Schwartz et al [3].
Materials and methods
The Technicon SMA 12/60
This instrument has been the subject of numerous reports
Broughton et al [1], "Iechnicon Bibliography [4] and needs no
further description. Standard Technicon analytical method-
ologies are employed at the Royal Berkshire Hospital with the
exception of albumin (bromocresol green) Northam et al [5],
alkaline phosphatase (disodium phenyl phosphate) Robinson
et al [6], phosphate (vanadate) Goldberg et al [7], and the use of
non-flowrated pump tubes.
The Vickers SP 120
This is a computer-controlled system designed to monitor and
control the Technicon instrument which is attached to it. The
system at the Royal Berkshire Hospital consists of an SP 120
process controller (made up of a Digital Equipment
Corporation PDP 8A computer, XEBEC flexible disc system,
Hewlett Packard scope and Vickers Medical analog electronics)
a Centronics 308 teleprinter capable of printing 165 characters
per second, 80 columns per line: a Pitney-Bowes laser beam bar
code reader for sample identification: and a Beehive Super-Bee
visual display unit. The process controller takes over the
functions of the 12/60 programmer and function monitor,
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while the analog presentation of results on chart paper is
replaced by a printout from the Centronics printer. The system
is fitted to an existing SMA by plugging into each of the
colorimeters and the sampler, the programmer having been
disconnected. The 12/60 programmer, chart recorder and
function monitor are switched off. The SP 120 eliminates
manual phasing and calculates a sample "inter-reaction"
correction to compensate for carryover.
Operation
Each day the process controller calculates the inter-reaction
corrections and the phasing times for each channel, from an
"Initial Tray" loaded with phasing solution and high and low
sera. The corrections and times taken from this tray are used
throughout the day or until another Initial Tray is run.
The analysis trays are run with two identical calibration
standards at the beginning and the end of each tray and the
results are calculated on the mean of these standards. When
analysis of the first tray is complete, the teleprinter puts out a
provisional report of the results and controls. Error messages
are printed out at any stage during the run to indicate poor
peaks or results beyond the scale of the channel and results
outside the laboratory limits are flagged. Poor phasing,during
the Initial Tray run is also flagged: the tray is then run again, or
phase times are edited manually.
The day’s run is started by the requisite "CHEM" program
processing an Initial Tray through the instrument. It takes the
timing for all subsequent readings from its first signal, the
phasing solution in cup 1. (Phasing solution: Wellcomtrol
"Autoset H Unassayed" Wellcome Reagents Ltd, for 25 ml
of solution, dissolved instead of 18 ml of the bicarbonate diluent
+ 2 ml of the 1000,ug% iron stock standard solution of the
routine analytical method + 20 ul Aspartate Transaminase
Suspension Sigma cat No G-2751 + 25 ul Technicon red chart
recorder ink + 25,ul Sheaffer Skrip or similar blue ink).
The other cups contain the prescribed sequence of high and
low sera or plasmas from which the program calculates
percentage interactions. (High and low serum or plasma: a
mixture of bovine with some human material, and an aqueous
1:10 dilution of this. The composition of this pooled serum or
plasma varies from day to day, and its actual concentrations are
immaterial. Typical values would be: Total Protein 85 g/l,
Albumin 43 g/l, Calcium 2.9 mmol/1, Phosphate 2.2 mmol/l,
Cholesterol 5.2 mmol/l, Iron 36umol/1, Urate 0.53 mmol/1,
Creatinine 700,umol/1, Total Bilirubin 100 umol/l, Alkaline
Phosphatase 200 IU/1, Lactate Dehydrogenase 550 IU/1,
Aspartate Transaminase I00 IU/1).
Trays are meanwhile loaded with test samples, each cup
carrying a barcoded identity label. These trays are then run.
They include calibration standards and, in cup positions 19 and
38, control sera (Ortho Diagnostics unassayed normal control
serum- Ortho Diagnostics Inc).
The standard and test voltages from the colorimeters are
stored until the tray is finished. The program then calculates
voltages for the standard and concentrations for the test and
control samples, identified by the tray nUmber, cup number and
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the sample number read by the laser beam. Fhese results are the
material of the provisional reports, printed individually per
patient who is identified only by these three numbers.
With a remote terminal the patients’ identification data can
be typed in and, on a subsequent command, merged with the
analytical data and again printed out, this time as fully
identified patient reports.
The quality control program is run at the end of the day’s
analyses, to give mean, SD, CV and SE of the control sera tested
that day. The same calculations can also be carried out for the
patient data and this operation may be restricted by using
exclusion limits.
A one-day summary of results is also printed, in alphabetical
order of patients.
A 30-minute wash-through period ends the working day.
Clinical laboratory evaluation
The basic difference between the two systems is a shorter
sampling time in the SP 120 complex, less than half that of the
SMA 12/60, with consequent changes in the final colorimetric
peak and the method required for reading it. These therefore
were the aspects examined.
The sampling and wash times for both systems were
measured with a stopwatch and compared with the theoretical
values taken from the programming. Sample volumes a
direct function of sampling times were calculated for each
system from the weighed contents of 40 cups. The proportional
volume of reagents used was calculated for two typical runs of
200 patients’ samples.
Linearity was measured in a series of samples placed in
ascending and descending order of concentrations. Adjoining
duplicates of these samples were loaded and analysed once each
on 3 days as part of runs standardised in the usual way, and the
second of each duplicate pair of results was taken. For most
channels the serum was Wellcomtrol Autoset H, dissolved in
less than the prescribed volume, and its aqueous dilutions to 80,
50, 40, 20 and 10 per cent. For the enzyme channels, sera from
patients were mixed in known proportions to give a series of
values.
Precision measurements, both intra-batch and inter-batch
were made by a 20-day comparison of 10 sets of results from
each system at high, medium and low levels using sera available
from Technicon Co Ltd., for SMA post-maintenance
performance checks. Drift was not measured separately but
deduced from the precision measurements.
A high-concentration and a low-concentration serum were
used to observe carryover. Wellcomtrol Autoset H was taken
for the high serum H and an aqueous 1"1 dilution of Ortho
Diagnostic normal control serum as the low serum L. This
measurement was taken on four days, on days and 3 of which
one sample plate of four low high sequences (samples loaded
as LLLLHHHHLLLLHHHHLLLLHHHHLLLLHHHH)
were analysed, while on the 2nd and 4th day the sequences were
reversed. There was one such run on both systems each day.
Results
The sampling time of the SMA 12/60 is programmed as 54 s, its
wash time as 6 s, and the SP 120 program cuts these times to 25
for sampling and a 5 wash. The values found in practice are
slightly but measurably different, 53 s and 4 for the SMA
12/60 cut to 24 and 3 by the SP 120. The sample volurnes
aspirated during these times (mean ,+SD of 40 measurements
each) are correspondingly reduced from 2.05 +_.0.012cm to 0.94
_+ 0.022 cm3, a saving of over half the sample, with a more
variable uptake (CV 0.59 for the SMA 12/60, 2.30 for the SP
120) which, given steady state conditions, does not seem to
affect the overall precision.
There is also a saving in reagents used with these samples,
though this is partly offset by the longer setting-up time
required by the SP 120 system (about 40 min, twice that of the
SMA 12/60 alone). A typical troubtefree run of setting up the
combined system and processing a batch of 200 samples with, in
Table Linearity of SP 120 SMA 12/60 complex analyser
Analysis Units R Intercept Slope
Total protein g/1 1.000 0.2 1.00
Albumin g/l 0.988 7.2 0.95
Calcium mmol/1 0.999 0 1.00
Phosphate mmol/1 0.999 0 0.99
Cholesterol mmol/l 0.993 0.7 0.97
Iron umol/1 0.990 -7.2 1.07
Urate mmol/l 0.999 0 0.99
Creatinine umol/1 0.999 38.3 0.97
Total bilirubin ,umol/1 1.000 -2.8 !.01
Alkaline
phosphatase IU 1.000 -4.9 i.01
LDH IU/I 0.999 14.9 0.99
AST IU/I 0.994 3.0 1.05
SD of
Points
1.24
5.83
1.21
1.75
4.52
5.78
1.51
1.92
1.21
9.23
2.07
4.74
Table 2 Number of days during the 20 day precision trial for which no
exclusions were made as a result of obvious faults
Low Serum Medium Serum High Serum
Analysis SP 120 SMA SP 120 SMA SP 120 SMA
12/60 12/60 12/60
Total protein
Albumin
Calcium
Phosphate
Cholesterol
Iron
Urate
Creatinine
Total bilirubin
Alkaline
phosphatase
LDH
AST
20 20
20 20
19 20
18 20
20 20
16 20
20 20
20 20
16 20
20 20
16 20
18 18
20 20
20 20
19 20
19 20
20 20
16 20
20 20
20 20
16 20
20 20
17 20
20 20
20 20
20 20
19 20
19 20
20 20
16 20
20 20
20 20
16 20
20 20
16 20
20 20
addition, their complement/of standard and control sera, will
require 66.5% of the reagent volume consumed for the same
load by the SMA 12/60.
The system shows good linearity over the ranges tested for the
individual channels. Linearity could be assumed for the SMA
12/60 but was checked in the case ofalbumin where at first sight
the SP 120 results seemed less obviously linear: there was no
difference between the two systems. Table gives the slopes and
intercepts of the regression lines for each channel together with
correlation coefficients R and SD of the points about the fitted
line.
Analytical precision was calculated on the results of the 20-
day trial of high medium and low sera. Those runs with data due
to malfunctioning analytical channels and faulty printouts
which were immediately obvious were excluded. This left the
data of runs showing their analytical precision and still
containing any faults that could go undetected in the course of
routine operation. Table 2 gives the number of days for each
machine and each level of sera on which no exclusions were
made. Table 3 gives the results of intra-batch precision as an
average within-day precision value over the 20 day period.
Table 4 places the inter-batch precision figures in their context
by comparing them with the recommended values for the
Technicon post-maintenance performance check.
There is no difference in performance of the urate and lactate
dehydrogenase (LDH) channels, and in three others, total
protein, calcium and low-level cholesterol (there is no difference
at medium and high levels) precision is lower but not to a
clinically noticeable degree. Two channels, bilirubin and
aspartate transaminase (AST) give results that are noticeably
worse at low concentration, and this being limited to the normal
range, where the clinical context tolerates wide variation will be
balanced against the definite fall-off in analytical precision.
Both channels right themselves at the two higher levels. The
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iron estimation appears precise only in mid-scale, and both ends
of the range show very marked deterioration. We feel that the
baseline value, which the SP 120 takes, may be interfered with
by the early rise curve of the iron channeI thus accounting for
the lower SP 120 values. The SMA 12/60 iron method (using
ferrozine) is a demanding one requiring exceptional attention to
its upkeep, and it seems that its present form will not stand up to
operation with half the sample at twice the rate.
Four channels show improvement in precision when
operated under SP 120 conditions. These are creatinine and
inorganic phosophorus, the clinically critical low level of
albumin (at higher concentrations the two systems are
equivalent) and alkaline phosphatase, particularly at the lower
end of our range.
An early impression or perhaps suspicion that mid-
point precisions might be best, with a general falling-off at the
end of ranges, was not confirmed by our results.
This impression does, however, remain in the inter-batch
precision (Table 5). Here the variations in bilirubin and, again,
iron stand out, together with the high-level alkaline
phosphatase results. In the day-to-day measurement ofAST the
SP 120 system is preferable, though it now appears best in the
clinically unimportant low range. For the rest, the two systems
perform about equally. The levels of performance are generally
acceptable except for high-level creatinine and low-level
bilirubin, in both of which an inadequate performance in the
Table 3 Root-Mean-Square value of each day’s intra-batch standard deviation (RMS.SD): means and coefficients of variation (as%) for three
concentration levels
Analysis Units Machine
Total protein g/l 12/60
Total protein g/1 SP120
Albumin g/l 12/60
Albumin g/l SPI20
Calcium mmol/l 12/60
Calcium mmol/l SPI20
Phosphate mmol/l 12/60
Phosphate mmol/! SPI20
Cholesterol mmol/l 12/60
Cholesterol mmol/l SPI20
Iron ,umol/1 12/60
Iron ,umol/1 SPI20
Urate mmol/l 12/60
Urate mmol/l SPI20
Creatinine mol/1 12/60
Creatinine pmol/1 SPI20
Total bilirubin ,/mol/l 12/60
Total bilirubin ,umol/l SPI20
Alkaline phosphatase IU!I 12/60
Alkaline phosphatase U SP 120
LDH IU/I -12/60
LDH IU/I SPI20
AST IU!I 12/60
AST IU/I SPI20
Low
RMS.SD Mean CV
0.68 45.0 1.51
0.81 45.0 1.81
0.53 27.0 1.96
0.48 27.0 1.77
0.029 2.02 1.45
0.043 2.05 2.08
0.040 0.84 4.76
0.029 0.81 3.64
0.08 2.3 3.48
0.11 2.2 5.15
0.43 18.8 2.34
1.91 13.10 14.5
0.004 0.21 2.
0.005 0.21 2.12
6.44 105.0 6.14
4.91 97.0 5.07
0.72 14.50 4.95
1.70 14.75 1.50
2.44 14.2 17.18
1.59 21.3 7.45
2.54 120.0 2.12
3.63 12.0 3.24
1.43 23.3 6.13
2.29 19.5 1.74
Medium
RMS.SD Mean CV
1’.04 62.0 1168
1.40 62.0 2.26
0.62 35.0 1.77
0.60 35.0 1.72
0.032 2.43 1.32
0.057 2.44 2.33
0.040 1.15 3.44
0.034 1.14 2.98
0.08 3.20 2.59
0.13 3.10 4.27
0.43 26.1 1.66
2.07 21.7 9.55
0.005 0.40 1.28
0.006 0.39 1.41
1.81 340.0 0.53
1.56 331.0 0.47
1.73 58.38 2.98
2.34 60.5 3.88
3.85 63.9 6.02
2.27 85.2 2.66
2.65 227.0 1.17
2.58 226.0 1.14
2.63 47.2 5.57
2.15 42.4 5.05
High
RMS.SD Mean CV
1.26 82.0 1.54
1.64 82.0 1.99
0.73 43.0 1.70
0.75 43.0 1.75
0.035 2.82 1.25
0.064 2.85 2.25
0.054 2.05 2.63
0.035 2.10 1.66
0.15 4.50 3.31
0.17 4.50 3.79
0.44 35.2 1.24
2.27 33.1 6.86
0.005 0.43 1.06
0.006 0.42 1.43
1.30 577.0 0.22
1.10 579.0 0.19
3.35 133.5 2.50
3.61 133.5 2.69
5.76 156.2 3.68
5.29 191.7 2.76
2.14 358.0 0.60
2.09 339.0 0.58
3.54 129.5 2.73
3.37 123.1 2.72
Table 4 Inter-batch precision of the two systems based on mean of daily means. Three sera (Technicon Ltd) at three concentration levels. Their
!inscribed values IV and values determined by the two systems are given in SI units, together with their variations (as SD). The SD orCV given with each
analysis is the maximum acceptable variation for the post maintenance performance checks of the SMA 12/60 agreed by DHSS and Technicon Co Ltd.
Analysis Units
Total protein g/l
SD 1.5
Albumin g/l
SD 1.3
Calcium mmol/l
SD 0.038
Phosphate mmol/l
SD 0.33
Cholesterol mmol/l
SD 0.19
Iron /zmol/l
Urate mmol/l
SD 0.012
Creatinine ,umol/l
CV 3% at 180
Total bilirubin jzmol/1
SD 1.7
Alkaline phosphate U
SD 5.0 at 200
LDH IU/I
CV 5%
AST IU/I
SD 2.5 at 100
Low
IV SMA SPI20
12/60
45 45 45
0.6 0.8
35 27 27
1.2 0.6
2.00 2.02 2.05
0.028 0.028
0.50 0.84 0.81
0.02 0.02
2.6 2.3 2.2
0.05 0.10
19 12
0.5 2.3
0.19 0.21 0.21
0.010 0.016
90 105 97
5.8 6.7
17 15 13
0.7 1.5
25 14 21.3
1.6 2.3
120 120 112
2.4 3.4
25 24 19
3.9 1.3
Medium
IV SMA SPI20
12/60
60 62 62
0.8 1.2
45 35 35
0.7 0.7
2.50 2.43 2.44
0.032 0.038
1.30 1.15 1.14
0.03 0.03
3.9 3.2 3.1
0.08 0.10
26 21
0.6 1.9
0.37 0.40 0.39
0.010 0.014
340 340 331
1.7 1.7
68 59 56
1.5 2.5
100 64 85
5.0 6.1
220 227 226
1.6 1.5
45 48 43
2.9 1.5
High
IV SMA SPI20
12/60
85 82 82
1.5 1.6
60 43 43
0.9 0.8
3.00 2.82 2.85
0.033 0.055
2.10 2.05 2.10
0.03 0.05
6.5 4.5 4.5
0.11 0.12
35 33
0.7 2.1
0.43 0.43 0.42
0.007 0.008
620 577 579
1.3 1.6
140 127 131
2.9 6.0
200 156 192
9.1 18.5
400 358 359
1.4 1.8
135 130 124
3.5 3.8
38 The Journal of Automatic ChemistryTable 5 Ratios of between-day SD values: SD SPI20/SD
SMA 12/60
Analysis
Total protein
Albumin
Calcium
Phosphate
Cholesterol
Iron
Urate
Creatinine
Total bilirubin
Alkaline phosphatase
LDH
AST
Low Medium Hgh
concentra- concentra- concentra-
tion tion tion
SD SD SD
Ratio Ratio Ratio
1.33 1.50 i07
0.50 1.00 0.89
1.00 1.18 1.67
1.00 1.00 1.67
2.00 1.5 1.09
4.60 3.17 3.00
1.60 1.40 1.14
1.07 1.O0 1.22
2.14 1.66 2.07
1.44 1.22 2.03
1.31 0.92 1.29
0.33 0.52 1.09
SD ratios in the range 0.70 to 1.40 show no real difference between the
machine for between-day precision. Ratios less than 0.50 give strong
indication that the SP 120 has less day-to-day variation, and ratios
above 2.00 indicate that the SP 120 has greater day-to-day variation
than the 12/60.
Table 6 Carryover. Mean 1% values of high-low and low-high
sequences/and the number of negative 1% results in each group
SMA 12/60 SPI20
Analysis High-low Low-high High-low Low-high
Total protein
Albumin
Calcium
Phosphate
Cholesterol
Iron
Urate
Creatinine
Total bilirubin
Alkaline phosphatase
LDH
AST
3.14/1 3.61/0
2.89/1 4.09/1
1.38/1 1.31 3
1.70/1 2.29/1
4.47/0 4.45/1
2.64/0 0.80/0
1.08/0 1.97/0
1.31/1 1.19/1
1.67/0 3.42/4
3.29/0 3.13/0
1.46/0 3.83/6
2.90/0 2.52/0
3.72/1 2.95/3
2.04/0 3.29/4
2.65/0 3.71/5
1.45/5 1.41/5
6.33/0 5.95/2
3.00/0 3.03/0
1.78/1 2.89/0
1.72/0 2.26/1
1.03/7 4.51/7
1.62/1 1.66/3
1.95/2 2.86/6
3.84/3 4.17/4
SMA 12/60 method is further sharpened under SP 120
conditions. The same sharpening effect is seen in the iron
method.
Neither intra-batch nor day-to-day precision data give any
indication of a significant drift effect in routine running
conditions but they do not disprove its presence. The SP 120
system improves the intra-batch analysis of AST, an SMA
12/60 channel susceptible to drift; given the same number of
samples, the improvement may be due to the shortened SP 120
running time halving the time available for drift to develop.
Our observations on carryover are recorded in Table 6. There
were 1.4 high low or low high sequences for each channel on
each system, with a few instances (bad traces on the SMA 12/60
or error messages on the SP 120) excluded. Carryover is
expressed in terms of Young and Gochman’s [8] I% interaction
value. Broughton et al[ 1] give 2% as the usual value for I% and
regard levels over 5% as unacceptable. None ofourSMA 12/60
means reach this figure, and only one SP 120 does, that for
cholesterol. This method already has the highest carryover in
the SMA 12/60 system, and SP 120 conditions bring out this
effect in both the high low andlow high sequence. Although
cholesterol is known as a difficult method, speeding up the
analysis has apparently affected only the inter-reaction between
viscous solutions, not its precision.
Negative values in the SMA 12/60 system probably have
random causes; additional instances amongst the SP 120 results
suggest over-correction by the inter-reaction calculation, and
there are sixty cases in our SP 120 compared to twenty-three in
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the SMA 12/60 series. Even in its present form, however, the
formula keeps carryover to an acceptable level inside the 5%
limit.
Discussion
Our teething troubles have been limited to the programming
(and in particular its response to mechanical events in theSMA
12/60). Low concentrations on two channels (bilirubin and
LDH) were on two occasions printed out as zero. On one
occasion failure of a colorimeter lamp spoilt two channels, but
no error message was printed. An air bubble passing through
the flow cell at a critical moment during Initial Tray readings
may give a wrong phasing time, faulty inter-reaction
calculation, or a high blank leading to falsely low results. Such a
mistake occurred three times without an error message showing
it, once while the bubble passing through the flow cell was
observed on the oscilloscope. Conversely, on one occasion error
messages were printed, though the oscilloscope had indicated
normal function. A highly efficient debubbler or a further
refinement in.software is needed to exclude this possibility.
The instrument can print a wider range of results, at least
twice that of the SMA 12/60 chart on some channels. The four
optical density ranges expand the scale to an extent where the
need to reanalyse above-scale samples almost disappears. Apart
from a longer setting-up time and some deterioration in results
(though improvement in others) the complex generally scores
and justifies the changes in operation. It can deal with an
increased turnover in that its optimal daily load is higher and
for medium-sized hospitals half-day running becomes
practicable. It reduces errors in patient identification and its
halving of test sample volumes becomes a financial saving on
standard and control sera.
An SP 120 run is less labour intensive than its SMA
equivalent since no resetting of drift standard is required and
the printed patient identities do away with worksheet
preparation. The daily manual phasing procedure is also taken
over entirely by the SP 120 program.
The complex is well adapted to operate routine SMA
methods, but where they operate close to critical variables,
these are magnified under SP 120 conditions. In particular, the
Liebermann Burchard-based cholesterol method requires
added care, and the ferrozine iron method should not be
installed. With these limitations, the SP 120 complex is a
successful adaptation of the widely used SMA series of
analysers.
The evaluation was carried out between January and June
1977. The manufacturers were informed of the teething troubles
listed in this discussion and took these into account in
subsequent modifications.
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